# EXECUTIVE SUMMARY - Q4 2024
## HEDIS Portfolio Optimizer ROI Report

---

## PERFORMANCE HIGHLIGHTS

| Metric | Value |
|--------|-------|
| **Total Investment** | $227,719.00 |
| **Estimated Revenue Impact** | $293,800.00 |
| **Net Benefit** | **$66,081.00** |
| **Overall ROI Ratio** | **1.29x** |
| **Successful Closures** | 2,938 |
| **Average Cost per Closure** | $77.51 |
| **Success Rate** | 42.4% |

---

## TOP 3 PERFORMING MEASURES (by ROI)

### 1. BPD - Blood Pressure Control for Patients with Diabetes
- **ROI:** **1.38x** | **Investment:** $18,776.00 | **Closures:** 259 | **Cost/Closure:** $72.49

### 2. SUPD - Follow-Up After Emergency Department Visit
- **ROI:** **1.37x** | **Investment:** $16,570.00 | **Closures:** 227 | **Cost/Closure:** $73.00

### 3. BCS - Breast Cancer Screening
- **ROI:** **1.35x** | **Investment:** $13,300.00 | **Closures:** 179 | **Cost/Closure:** $74.30

---

## MOST COST-EFFECTIVE INTERVENTIONS

| Rank | Intervention Type | Cost/Closure | Success Rate | Closures |
|------|-------------------|--------------|--------------|----------|
| **1** | **Automated Reminder System** | **$6.00** | 44.4% | 201 |
| **2** | **Member Portal Notification** | **$12.00** | **48.5%** | 207 |
| **3** | **Text Message** | **$30.00** | 40.6% | 176 |

---

## MOST EXPENSIVE MEASURES (by Cost per Closure)

| Rank | Measure | Measure Name | Cost/Closure | Investment | Closures |
|------|---------|--------------|--------------|------------|----------|
| 1 | CBP | Controlling High Blood Pressure | $83.86 | $24,152.00 | 288 |
| 2 | COL | Colorectal Cancer Screening | $83.44 | $17,772.00 | 213 |
| 3 | GSD | Glycemic Status Assessment for Diabetes | $79.24 | $19,097.00 | 241 |

---

## BUDGET DISCIPLINE METRICS

| Metric | Value |
|--------|-------|
| **Total Budget (Q4 2024)** | $520,000.00 |
| **Total Spent** | $540,410.00 |
| **Budget Utilization** | 103.9% |
| **Measures Over Budget** | 8 of 12 |
| **Measures Under Budget** | 4 of 12 |

---

## BUSINESS IMPACT STATEMENT

In Q4 2024, our HEDIS Portfolio Optimizer delivered exceptional results: investing **$227,719** across 12 HEDIS measures to achieve **2,938 successful gap closures**, generating an estimated **$293,800 in revenue impact**. With a **1.29x ROI ratio** and **$66,081 net benefit**, this demonstrates data-driven decision-making and measurable business value in healthcare analytics.

**Key Achievements:**
- ✅ All 12 measures showing positive ROI (1.19x - 1.38x)
- ✅ 42.4% intervention success rate
- ✅ $77.51 average cost per closure
- ✅ Top performer (BPD) achieving 1.38x ROI
- ✅ Most efficient intervention (Automated Reminder) at $6 per closure

**Strategic Insights:**
- Low-touch digital interventions deliver highest cost efficiency
- Blood Pressure Control (BPD) leads portfolio with best ROI performance
- Budget variance analysis enables proactive resource allocation
- Data-driven approach enables continuous optimization

---

**Report Generated:** November 19, 2025  
**Period:** October 1, 2024 - December 31, 2024  
**Data Source:** HEDIS Portfolio Optimizer - Phase 3 ROI Analysis

